During the last session, NeuroSense Therapeutics Ltd (NASDAQ:NRSN)’s traded shares were 0.49 million, with the beta value of the company hitting 1.56. At the end of the trading day, the stock’s price was $1.27, reflecting an intraday gain of 1.59% or $0.02. The 52-week high for the NRSN share is $2.33, that puts it down -83.46 from that peak though still a striking 66.14% gain since the share price plummeted to a 52-week low of $0.43. The company’s market capitalization is $24.73M, and the average intraday trading volume over the past 10 days was 0.21 million shares, and the average trade volume was 294.92K shares over the past three months.
NeuroSense Therapeutics Ltd (NASDAQ:NRSN) trade information
NeuroSense Therapeutics Ltd (NRSN) registered a 1.59% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 1.59% in intraday trading to $1.27, hitting a weekly high. The stock’s 5-day price performance is -0.01%, and it has moved by 4.09% in 30 days. Based on these gigs, the overall price performance for the year is 178.91%. The short interest in NeuroSense Therapeutics Ltd (NASDAQ:NRSN) is 0.24 million shares and it means that shorts have 1.52 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NeuroSense Therapeutics Ltd (NRSN) estimates and forecasts
Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -260.00% this quarter and then jump 25.00% in the quarter after that.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -7.06%. While earnings are projected to return 33.73% in 2024.
NRSN Dividends
NeuroSense Therapeutics Ltd is due to release its next quarterly earnings on 2024-Nov-01. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 40000.0 shares, is of MEITAV INVESTMENT HOUSE LTD’s that is approximately 0.2597% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $44800.0.
